Clinical trial
Efficacy of Pentoxifylline as Add on Therapy in COVID19 Patients
NCT04433988 is registered in ClinicalTrials.gov with Sadat City University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Pentoxifylline as Add on Therapy in COVID19 Patients
- Lead sponsor
- Sadat City University
- Phase
- Phase 1/2
- Overall status
- Withdrawn
- Start date
- November 13, 2022
- Completion date
- December 30, 2022
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid